Biogen (BIIB) financial statements

+211.8%since 2007
FY2025 revenue
$9.9B▲ +2.2%
FY2025 net income
$1.3B▼ −20.8%
FY2025 diluted EPS
$8.79▼ −21.4%
FY2025 free cash flow
$2.1B▼ −24.7%

Biogen income statement

Biogen income statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Revenue9,8919,6769,836
Pretax income1,5571,9061,297
Net income1,2931,6321,161
Diluted earnings per share8.7911.187.97

Biogen balance sheet

Biogen balance sheet
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Cash and cash equivalents3,0092,3751,050
Total assets29,44028,04926,845
Total liabilities11,18311,33312,045
Total equity18,25716,71614,799

Biogen cash flow statement

Biogen cash flow statement
USD millionsFY2025FY2024FY2023
Period ended31 Dec 202531 Dec 202431 Dec 2023
Operating cash flow2,2052,8761,547
Capital expenditure-154-154-277
Free cash flow (derived)2,0512,7221,270
Share repurchasesn/a00

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended30 Sep 202630 Jun 202631 Mar 202631 Dec 2025
Revenue (derived)2,8042,7362,4782,279
Net income (derived)-2198320-49
Diluted earnings per share-0.140.662.15n/a
Operating cash flow (derived)641449646512
Total assets32,05432,08729,48329,440

Biogen major shareholders

Biogen major shareholders
HolderShare of classSharesFiled
Abigail P. Johnson12.4%18,294,5246 August 2026
FMR LLC12.4%18,294,5246 August 2026
PRIMECAP MANAGEMENT CO/CA/10.2%14,954,69714 November 2025
BlackRock, Inc.8.5%12,506,68117 April 2025
Vanguard Capital Management7.5%10,989,56230 April 2026

Biogen 10-K and SEC filings

Biogen 10-K and SEC filings
FiledFormTypeDescription
28 October 202610-QQuarterly reportQuarterly report
28 October 20268-KCurrent reportCurrent report
29 July 202610-QQuarterly reportQuarterly report
29 July 20268-KCurrent reportCurrent report
1 July 20268-KCurrent reportCurrent report
10 June 20268-KCurrent reportCURRENT REPORT
14 May 20268-KCurrent reportCurrent report
29 April 202610-QQuarterly reportQuarterly report

Common questions

What was Biogen's revenue in fiscal 2025?

Biogen reported $9.9 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 2.2% from fiscal 2024.

What was Biogen's net income in fiscal 2025?

Biogen reported net income of $1.3 billion for fiscal 2025, the year ended 31 December 2025, down 20.8% from fiscal 2024. Diluted earnings per share were $8.79.

What was Biogen's free cash flow in fiscal 2025?

Biogen had $2.1 billion in free cash flow in fiscal 2025. Operating cash flow was $2.2 billion and capital expenditure was $154 million.

What were Biogen's total assets at the end of fiscal 2025?

Biogen reported total assets of $29.4 billion at the end of fiscal 2025, the year ended 31 December 2025.

How much Biogen history does each plan include?

Free covers the last 3 fiscal years of annual figures. Basic covers the last 10 fiscal years, annual and quarterly. Pro covers the full history, with first reported values and as of dates.